Integrated Diagnostics Holdings Future Growth
Future criteria checks 5/6
Integrated Diagnostics Holdings is forecast to grow earnings and revenue by 27.9% and 19.4% per annum respectively. EPS is expected to grow by 37.8% per annum. Return on equity is forecast to be 33% in 3 years.
Key information
27.9%
Earnings growth rate
37.8%
EPS growth rate
Healthcare earnings growth | 23.8% |
Revenue growth rate | 19.4% |
Future return on equity | 33.0% |
Analyst coverage | Low |
Last updated | 15 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 7,637 | 1,282 | N/A | N/A | 2 |
12/31/2025 | 6,549 | 982 | N/A | N/A | 2 |
12/31/2024 | 5,415 | 822 | N/A | N/A | 2 |
12/31/2023 | 4,123 | 510 | 218 | 544 | N/A |
9/30/2023 | 3,858 | 538 | 190 | 514 | N/A |
6/30/2023 | 3,523 | 342 | 5 | 335 | N/A |
3/31/2023 | 3,340 | 417 | -362 | -1 | N/A |
12/31/2022 | 3,605 | 541 | -100 | 209 | N/A |
9/30/2022 | 4,258 | 716 | 417 | 700 | N/A |
6/30/2022 | 4,886 | 1,188 | 1,117 | 1,438 | N/A |
3/31/2022 | 5,276 | 1,383 | 1,824 | 2,091 | N/A |
12/31/2021 | 5,225 | 1,413 | 2,006 | 2,270 | N/A |
9/30/2021 | 4,753 | 1,322 | 1,923 | 2,153 | N/A |
6/30/2021 | 4,000 | 1,062 | 1,446 | 1,600 | N/A |
3/31/2021 | 3,286 | 816 | N/A | N/A | N/A |
12/31/2020 | 2,656 | 594 | 757 | 883 | N/A |
9/30/2020 | 2,247 | 523 | N/A | N/A | N/A |
6/30/2020 | 2,115 | 466 | 452 | 621 | N/A |
3/31/2020 | 2,180 | 491 | N/A | N/A | N/A |
12/31/2019 | 2,226 | 511 | 479 | 697 | N/A |
9/30/2019 | 2,193 | 508 | N/A | N/A | N/A |
6/30/2019 | 2,117 | 510 | 287 | 621 | N/A |
3/31/2019 | 2,035 | 518 | N/A | N/A | N/A |
12/31/2018 | 1,921 | 502 | 225 | 556 | N/A |
9/30/2018 | 1,790 | 447 | N/A | N/A | N/A |
6/30/2018 | 1,695 | 435 | 273 | 434 | N/A |
3/31/2018 | 1,605 | 405 | 260 | 418 | N/A |
12/31/2017 | 1,514 | 374 | 246 | 403 | N/A |
9/30/2017 | 1,425 | 343 | N/A | N/A | N/A |
6/30/2017 | 1,303 | 292 | N/A | 416 | N/A |
3/31/2017 | 1,237 | 276 | N/A | 407 | N/A |
12/31/2016 | 1,171 | 260 | N/A | 399 | N/A |
9/30/2016 | 1,116 | 247 | N/A | N/A | N/A |
6/30/2016 | 1,074 | 251 | N/A | 311 | N/A |
3/31/2016 | 1,044 | 198 | N/A | 250 | N/A |
12/31/2015 | 1,015 | 145 | N/A | 190 | N/A |
9/30/2015 | 980 | 134 | N/A | N/A | N/A |
6/30/2015 | 937 | 93 | N/A | 212 | N/A |
3/31/2015 | 898 | 113 | N/A | 257 | N/A |
12/31/2014 | 860 | 133 | N/A | 302 | N/A |
9/30/2014 | 807 | 105 | N/A | N/A | N/A |
12/31/2013 | 672 | 62 | N/A | 209 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 8I8's forecast earnings growth (27.9% per year) is above the savings rate (0.6%).
Earnings vs Market: 8I8's earnings (27.9% per year) are forecast to grow faster than the German market (14.9% per year).
High Growth Earnings: 8I8's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 8I8's revenue (19.4% per year) is forecast to grow faster than the German market (5.4% per year).
High Growth Revenue: 8I8's revenue (19.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 8I8's Return on Equity is forecast to be high in 3 years time (33%)